Company / Gross Profit
Entera Bio Ltd. Gross Profit History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$9.0K
FY2025
5-year range
$0 / $198.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit returned to growth in FY2025 after 2 years of decline, reaching $9,000.
Based on SEC 10-K filings.
$9,000 in FY2025 with a 3-year CAGR of -64.3%.
Declined from $33,000 to $9,000 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -64.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -64.3%, indicating a declining trend.
- Peak gross profit was recorded in FY2022.
- Lowest gross profit in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.0K | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $33.0K | -83.3% |
| FY2022 | $198.0K | +204.6% |
| FY2021 | $65.0K | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026